These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 18929111)

  • 1. The management of exfoliative glaucoma.
    Ritch R
    Prog Brain Res; 2008; 173():211-24. PubMed ID: 18929111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Directed Therapy: An Approach to the Improved Treatment of Exfoliation syndrome.
    Angelilli A; Ritch R
    Middle East Afr J Ophthalmol; 2009 Jan; 16(1):35-40. PubMed ID: 20142958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From epidemiology to lysyl oxidase like one (LOXL1) polymorphisms discovery: phenotyping and genotyping exfoliation syndrome and exfoliation glaucoma in Iceland.
    Jonasson F
    Acta Ophthalmol; 2009 Aug; 87(5):478-87. PubMed ID: 19664108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular pathology of pseudoexfoliation syndrome/glaucoma--new insights from LOXL1 gene associations.
    Schlötzer-Schrehardt U
    Exp Eye Res; 2009 Apr; 88(4):776-85. PubMed ID: 18809397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of LOXL1 gene with Finnish exfoliation syndrome patients.
    Lemmelä S; Forsman E; Onkamo P; Nurmi H; Laivuori H; Kivelä T; Puska P; Heger M; Eriksson A; Forsius H; Järvelä I
    J Hum Genet; 2009 May; 54(5):289-97. PubMed ID: 19343041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and regulation of LOXL1 and elastin-related genes in eyes with exfoliation syndrome.
    Zenkel M; Schlötzer-Schrehardt U
    J Glaucoma; 2014; 23(8 Suppl 1):S48-50. PubMed ID: 25275906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Common sequence variants in the LOXL1 gene confer susceptibility to exfoliation glaucoma.
    Thorleifsson G; Magnusson KP; Sulem P; Walters GB; Gudbjartsson DF; Stefansson H; Jonsson T; Jonasdottir A; Jonasdottir A; Stefansdottir G; Masson G; Hardarson GA; Petursson H; Arnarsson A; Motallebipour M; Wallerman O; Wadelius C; Gulcher JR; Thorsteinsdottir U; Kong A; Jonasson F; Stefansson K
    Science; 2007 Sep; 317(5843):1397-400. PubMed ID: 17690259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Relevance of the pseudoexfoliation syndrome for the glaucomas].
    Schlötzer-Schrehardt U; Küchle M; Jünemann A; Naumann GO
    Ophthalmologe; 2002 Sep; 99(9):683-90. PubMed ID: 12219256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of high-risk alleles in the LOXL1 gene and its association with pseudoexfoliation syndrome and exfoliation glaucoma in a Latin American population.
    Jaimes M; Rivera-Parra D; Miranda-Duarte A; Valdés G; Zenteno JC
    Ophthalmic Genet; 2012 Mar; 33(1):12-7. PubMed ID: 21970694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The LOXL1 gene variations are not associated with primary open-angle and primary angle-closure glaucomas.
    Chakrabarti S; Rao KN; Kaur I; Parikh RS; Mandal AK; Chandrasekhar G; Thomas R
    Invest Ophthalmol Vis Sci; 2008 Jun; 49(6):2343-7. PubMed ID: 18223248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exfoliation syndrome.
    Ritch R; Schlötzer-Schrehardt U
    Surv Ophthalmol; 2001; 45(4):265-315. PubMed ID: 11166342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spontaneous, bilateral intraocular lens dislocation in a patient with exfoliation syndrome.
    Rutner D; Madonna RJ
    Optometry; 2007 May; 78(5):220-4. PubMed ID: 17478339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential gene expression in pseudoexfoliation syndrome.
    Zenkel M; Pöschl E; von der Mark K; Hofmann-Rummelt C; Naumann GO; Kruse FE; Schlötzer-Schrehardt U
    Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3742-52. PubMed ID: 16186358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LOXL1 gene sequence variants and vascular disease in exfoliation syndrome and exfoliative glaucoma.
    Holló G; Gál A; Kóthy P; Molnár JM
    J Glaucoma; 2011 Mar; 20(3):143-7. PubMed ID: 20436359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genotype-correlated expression of lysyl oxidase-like 1 in ocular tissues of patients with pseudoexfoliation syndrome/glaucoma and normal patients.
    Schlötzer-Schrehardt U; Pasutto F; Sommer P; Hornstra I; Kruse FE; Naumann GO; Reis A; Zenkel M
    Am J Pathol; 2008 Dec; 173(6):1724-35. PubMed ID: 18974306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of LOXL1 protein and Apolipoprotein E as components of surgically isolated pseudoexfoliation material by direct mass spectrometry.
    Sharma S; Chataway T; Burdon KP; Jonavicius L; Klebe S; Hewitt AW; Mills RA; Craig JE
    Exp Eye Res; 2009 Oct; 89(4):479-85. PubMed ID: 19442659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pseudoexfoliation syndrome--etiopatogenesis and clinical course].
    Ludwisiak-Kocerba L; Hevelke A; Kecik D
    Klin Oczna; 2006; 108(1-3):82-6. PubMed ID: 16883948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ocular and systemic manifestations of exfoliation syndrome.
    Ritch R
    J Glaucoma; 2014; 23(8 Suppl 1):S1-8. PubMed ID: 25275896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of lysyl oxidase-like 1 (LOXL1) in exfoliation syndrome and glaucoma.
    Schlötzer-Schrehardt U; Zenkel M
    Exp Eye Res; 2019 Dec; 189():107818. PubMed ID: 31563608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular Matrix Regulation and Dysregulation in Exfoliation Syndrome.
    Zenkel M
    J Glaucoma; 2018 Jul; 27 Suppl 1():S24-S28. PubMed ID: 29432335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.